Immediate Impact
14 standout
Citing Papers
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A
2023 Standout
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
2022 Standout
Works of Declan Noone being referenced
A survey of the outcome of prophylaxis, on‐demand treatment or combined treatment in 18–35‐year old men with severe haemophilia in six countries
2012
Haemophilia care in Europe: a survey of 19 countries
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Declan Noone | 563 | 81 | 67 | 69 | 51 | 669 | |
| Judith Baker | 576 | 134 | 41 | 68 | 33 | 713 | |
| Brenda Riske | 562 | 79 | 39 | 74 | 32 | 674 | |
| Xiong Ni | 337 | 84 | 120 | 74 | 50 | 619 | |
| R. Besuyen | 237 | 93 | 132 | 34 | 41 | 667 | |
| Jeremy P. Wood | 466 | 190 | 20 | 107 | 33 | 778 | |
| Riad El Fakih | 260 | 89 | 202 | 99 | 75 | 617 | |
| A Bröcker-Vriends | 387 | 109 | 134 | 175 | 26 | 833 | |
| Shannon Jackson | 626 | 189 | 31 | 123 | 62 | 823 | |
| David Szwajcer | 480 | 103 | 252 | 80 | 39 | 842 | |
| Adnan Abdul Jabbar | 283 | 172 | 147 | 203 | 51 | 806 |
All Works
Login with ORCID to disown or claim papers
Loading papers...